Highlights from the American Academy of Neurology 2010: An Update for Payers and Pharmacists on Multiple Sclerosis
Jack S. Burks, MD

Payer Perspectives on Breast Cancer: Updates from the National Comprehensive Cancer Network 15th Annual Conference

Long-Term Care: Implications of Overactive Bladder and the Latest Treatment Options for Quality Care
Eric G. Tangalos, MD, FACP, AGSF, CMD

Long-Term Care: Implications of Deep-Vein Thrombosis and the Latest Treatment Options for Quality Care
John A. Heit, MD; John Fanikos, RPh, MBA

Specialty Pharmaceutical Utilization Strategies for Use of Biologic Response Modifiers
Robert Navarro, PharmD; Jack Burks, MD; Elizabeth Mauer, PharmD, MBA; Thomas Bramley, RPh, PhD

Multiple Myeloma and Health Economics: Highlights from the 2009 ASH Annual Meeting
William J. Cardarelli, PharmD

The 32^nd Annual San Antonio Breast Cancer Symposium Highlights: A Payer's and Pharmacist's Perspective
James Kenney, RPh, MBA

NCCN Updated Guidelines for Breast Cancer: A Payer's Perspective
Gary Rice, RPh, MS, MBA

Pharmaceutical Research & Development in a Value-Based Healthcare System
Thomas McCarter, MD, FACP; Nirav R. Shah, MD, MPH, FACP; Kip Piper, MA, FACHE; Matthew Sarnes, PharmD; & Michael F. Murphy, MD, PhD

Health Economics in the Treatment of Multiple Myeloma:
Highlights from Recent Oncology Meetings
Robyn Graham, PharmD

Value-Based Benefit Design

Workplace Wellness and Disease Prevention: Focus on Stroke
By Dana Delibovi

Workplace Wellness and Disease Prevention: Focus on COPD
David Tinkelman, MD; William B. Bunn, III, MD, JD, MPH; F. Randy Vogenberg, RPh, PhD

Value-Based Oncology Benefit Design

Balancing Cost, Quality, and Access in Chronic Myelogenous Leukemia Treatment
Bonnie J. May, RPh, MBA; Lisa Schulmeister, RN, MN, APRN-BC, OCN, FAAN; & Michael N. Baxley, MD, MS, MPH

Balancing Cost, Quality, and Access in Cancer Care
Gary M. Owens, MD; Al B. Benson, III, MD, FACP; & Gary Rice, RPh, MS, MBA

Breast Cancer, Multiple Myeloma, and Prostate Cancer
Kavita V. Nair, PhD; Gary M. Owens, MD; & Al B. Benson III, MD, FACP

Balancing Cost, Quality, and Access in Colorectal Cancer Care
Gary M. Owens, MD & John L. Fox, MD, MHA

Drug Update A Complete Resource for New Drug Approvals and Indications in 2009

A Wellness-Based Healthcare System for Chronic Diseases: Prevention, Intervention, and Innovation

Optimizing Outcomes in Asthma through a Pay-for-Quality-Performance Program
Allan T. Laskin, MD; Thomas James III, MD; Nicole G. Devita, RPh, MPH

Prescription Drug Benefit Cost and Plan Design Report: US Employers Begin to Adopt Value-Based Drug Plan Designs
Dana H. Felthouse, MBA; David E. Hickman, PharmD

Savella (Milnacipran HCl): A New Option for the Management of Fibromyalgia
By Loretta Fala
Stakeholder Perspectives
Nirav R. Shah, MD, MPH; Gary M. Owens, MD; Philip Mease, MD


TIA AND RECURRENT STROKE
Prevention and Treatment Strategies: Aligning Payer, Purchaser, Provider, and Patient Goals

Thomas McCarter, MD, FACP; Nirav R. Shah, MD, MPH; Mitchell S.V. Elkind, MD, MS; Kathryn Fitch, RN, MEd; Robert J. Adams, MS, MD; Barbara Lennert, RN, BSN, CRRN, MAOM; Kip Piper, MA, FACHE;
Alberto M. Colombi, MD, MPH

Prescription Drug Benefit Cost and Plan Design Report Supplement - September/October 2009
Dana H. Felthouse, MBA; Scott R. Taylor, RPh, MBA

Clinical and Cost Benefits of Abraxane for Breast Cancer Therapy
Robert E. Henry; George Dranitsaris, MPharm, FCSHP; William Gradishar, MD, FACFP; Beth Overmoyer, MD

Drug Update: A Complete Resource for New Drug Approvals and Indications in 2008

Evidence-Based Approach to Methicillin-Resistant Staphylococcus aureus:
Epidemiology, Pharmacotherapy, and Prevention Strategies
J.B. Jones, PhD, MBA; Walter F. Stewart, PhD, MPH; Hien H. Nguyen, MD; & Leslie S. Fish, PharmD

The Return to Deep Science: Pharmaceutical Research & Development in a Value-Based Healthcare System
Proceedings from AHDB's First Annual Summit on Healthcare Stakeholder Integration
Robert E. Henry; Thomas McCarter, MD, FACP; Keri Cooper; Alicia Mettimano; Robert K. Smoldt, BS, MBA; Gary M. Owens, MD; F. Randy Vogenberg, RPh, PhD; Wayne M. Lednar, MD, PhD; Lawton Robert Burns, PhD, MBA; Kip Piper, MA, CHE; Nirav R. Shah, MD, MPH; Jeff J. Guo, BPharm, PhD; Christina M. L. Kelton, PhD; Matthew Sarnes, PharmD; Michael F. Murphy, MD, PhD

The Strategic Role of Compendia in Cancer Drug Coverage, Part 2
John Cox, MD; Samuel M. Silver, MD, PhD; Al B. Benson, III, MD, FACP

Drug Delivery Systems for Administration of Inhaled Therapies in Patients with
Chronic Obstructive Pulmonary Disease
Myrna B. Dolovich, PEng; Robert Filuk, MD, FRCPC, FACP, FCCP; James T. Kenney, Jr, RPh, MBA